Literature DB >> 34291197

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenström Macroglobulinemia.

Amanda Kofides1, Zachary R Hunter1,2, Lian Xu1, Nicholas Tsakmaklis1, Maria G Demos1, Manit Munshi1, Xia Liu1, Maria Luisa Guerrera1, Carly R Leventoff1, Timothy P White1, Catherine A Flynn1, Kirsten Meid1, Christopher J Patterson1, Guang Yang1,2, Andrew R Branagan2,3, Shayna Sarosiek1,2, Jorge J Castillo1,2, Steven P Treon1,2, Joshua N Gustine1,4.   

Abstract

Entities:  

Year:  2021        PMID： 34291197      PMCID： PMC8288895          DOI： 10.1097/HS9.0000000000000624

Source DB:  PubMed          Journal:  Hemasphere        ISSN： 2572-9241


× No keyword cloud information.
  23 in total

1.  MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.

Authors:  Steven P Treon; Lian Xu; Zachary Hunter
Journal:  N Engl J Med       Date:  2015-08-06       Impact factor: 91.245

2.  MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.

Authors:  Steven P Treon; Joshua Gustine; Lian Xu; Robert J Manning; Nicholas Tsakmaklis; Maria Demos; Kirsten Meid; Maria L Guerrera; Manit Munshi; Gloria Chan; Jiaji Chen; Amanda Kofides; Christopher J Patterson; Guang Yang; Xia Liu; Patricia Severns; Toni Dubeau; Zachary R Hunter; Jorge J Castillo
Journal:  Br J Haematol       Date:  2017-11-27       Impact factor: 6.998

3.  Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Nickolas Tsakmaklis; Maria G Demos; Amanda Kofides; Cristina Jimenez; Gloria G Chan; Jiaji Chen; Xia Liu; Manit Munshi; Joshua Gustine; Kirsten Meid; Christopher J Patterson; Guang Yang; Toni Dubeau; Mehmet K Samur; Jorge J Castillo; Kenneth C Anderson; Nikhil C Munshi; Steven P Treon
Journal:  Blood Adv       Date:  2018-11-13

4.  Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia.

Authors:  Yan-Yan Wu; Ming-Nan Jia; Hao Cai; Yu Qiu; Dao-Bin Zhou; Jian Li; Xin-Xin Cao
Journal:  Ann Hematol       Date:  2020-06-23       Impact factor: 3.673

5.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

Review 6.  Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia.

Authors:  Jorge J Castillo; Ranjana H Advani; Andrew R Branagan; Christian Buske; Meletios A Dimopoulos; Shirley D'Sa; Marie José Kersten; Veronique Leblond; Monique C Minnema; Roger G Owen; M Lia Palomba; Dipti Talaulikar; Alessandra Tedeschi; Judith Trotman; Marzia Varettoni; Josephine M Vos; Steven P Treon; Efstathios Kastritis
Journal:  Lancet Haematol       Date:  2020-11       Impact factor: 18.959

7.  Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.

Authors:  Michael J Kluk; R Coleman Lindsley; Jon C Aster; Neal I Lindeman; David Szeto; Dimity Hall; Frank C Kuo
Journal:  J Mol Diagn       Date:  2016-07       Impact factor: 5.568

Review 8.  Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.

Authors:  Steven P Treon; Lian Xu; Maria Luisa Guerrera; Cristina Jimenez; Zachary R Hunter; Xia Liu; Maria Demos; Joshua Gustine; Gloria Chan; Manit Munshi; Nicholas Tsakmaklis; Jiaji G Chen; Amanda Kofides; Romanos Sklavenitis-Pistofidis; Mark Bustoros; Andrew Keezer; Kirsten Meid; Christopher J Patterson; Antonio Sacco; Aldo Roccaro; Andrew R Branagan; Guang Yang; Irene M Ghobrial; Jorge J Castillo
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

9.  Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.

Authors:  Tina Bagratuni; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Nefeli Mavrianou-Koutsoukou; Christine Liacos; Dimitrios Patseas; Nikolaos Kanellias; Magdalini Migkou; Dimitrios C Ziogas; Evangelos Eleutherakis-Papaiakovou; Maria Roussou; Despina Fotiou; Evangelos Terpos; Efstathios Kastritis; Meletios A Dimopoulos
Journal:  Leukemia       Date:  2018-07-19       Impact factor: 11.528

10.  HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.

Authors:  Guang Yang; Sara J Buhrlage; Li Tan; Xia Liu; Jie Chen; Lian Xu; Nicholas Tsakmaklis; Jiaji G Chen; Christopher J Patterson; Jennifer R Brown; Jorge J Castillo; Wei Zhang; Xiaofeng Zhang; Shuai Liu; Philip Cohen; Zachary R Hunter; Nathanael Gray; Steven P Treon
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113
View more
  3 in total

1.  [Exploring the detection of MYD88 mutation in patients with Waldenström macroglobulinemia by different methods and specimens].

Authors:  Y Tao; Z K Pan; S Wang; L Wang; W L Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-05-14

Review 2.  Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia.

Authors:  Francesco Piazza; Veronica Di Paolo; Greta Scapinello; Sabrina Manni; Livio Trentin; Luigi Quintieri
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 3.  Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.

Authors:  Daniela Drandi; Philippe Decruyenaere; Martina Ferrante; Fritz Offner; Jo Vandesompele; Simone Ferrero
Journal:  Diagnostics (Basel)       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.